University of California, Davis Shifa Community Clinic
Sacramento, California, 95818, United States
NCT Number: NCT01820234
The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event.
The investigators' hypotheses include the following:
1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. 2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. 3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sacramento, California, 95818, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Every patient will be evaluated by an in person dermatologist present at the screening.
Every patient will be evaluated online via a store and forward teledermatology modality.
Other names: Health care modality
Time frame: At the time of dermatologist evaluation (Day 1)
Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.
Time frame: At the time of dermatologist evaluation (Day 1)
Diagnostic concordance between the in-person dermatologist and the teledermatologist for their primary diagnosis.
Time frame: At the time of dermatologist evaluation (Day 1)
Diagnostic concordance between the in-person dermatologist and teledermatologist based on standard clinical diagnostic categories for each lesion.
Time frame: At the time of dermatologist evaluation (Day 1)
The concordance between the in-person dermatologist and teledermatologist for the chosen management plan for each lesion.
Time frame: At the time of dermatologist evaluation (Day 1)
The sensitivity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.
Time frame: At the time of dermatologist evaluation (Day 1)
The specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.
University of California, Davis
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01535963
Neoplasms, Neoplasms by Site
Chicago, Illinois, United States
View Trial DetailsNCT07670403
Basal Cell Carcinoma of Skin, Behavior
Chengdu, Sichuan, China
View Trial DetailsNCT05313711
Neoplasms, Neoplasms by Site
Aberdeen, United Kingdom
View Trial DetailsNCT05774600
Neoplasms, Neoplasms by Site
Golden, Colorado, United States
View Trial Details